Watson Pharmaceuticals (WPI) Tops Q3 EPS by 4c; Updates FY11 Outlook
Tweet
Share
E-mailGet Alerts WPI Hot Sheet
Price: $85.73 --0%
Financial Fact:
Total operating expenses: 1.86B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total operating expenses: 1.86B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Watson Pharmaceuticals, Inc. (NYSE: WPI) reported Q3 EPS of $1.09, $0.04 better than the analyst estimate of $1.05. Revenue for the quarter came in at $1.08 billion versus the consensus estimate of $1.09 billion.
Watson Pharmaceuticals, Inc. sees FY2011 EPS of $4.55-$4.65, versus the consensus of $4.48. Watson Pharmaceuticals, Inc. sees FY2011 revenue of $4.5 billion, versus the consensus of $4.50 billion.
Watson Pharmaceuticals, Inc. sees FY2011 EPS of $4.55-$4.65, versus the consensus of $4.48. Watson Pharmaceuticals, Inc. sees FY2011 revenue of $4.5 billion, versus the consensus of $4.50 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
